Early abciximab administration before primary percutaneous coronary intervention improves clinical outcome in elderly patients transferred with ST-elevation myocardial infarction: Data from the EUROTRANSFER registry

International Journal of Cardiology

Volumn 143, Issue 2, 2010, Pages 147-153

  Dziewierz, Artur ^a   Siudak, Zbigniew ^a   Rakowski, Tomasz ^a   Chyrchel, Micha ^a   Mielecki, Waldemar ^a   Janzon, Magnus ^b   Birkemeyer, Ralf ^c   Tierala, Ilkka ^d   Wojdya, Roman M ^a   Dubiel, Jacek S ^a   Dudek, Dariusz ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c Schwarzwald Baar Klinikum Villingen Schwenningen   (Germany)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Abciximab; Angioplasty; Bleeding complications; Elderly; Myocardial infarction; Registries

Indexed keywords

ABCIXIMAB;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; BLEEDING; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART MUSCLE REPERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURGICAL MORTALITY; TREATMENT OUTCOME; VASCULAR PATENCY;

AGE DISTRIBUTION; AGED; ANGIOPLASTY, BALLOON, CORONARY; ANTIBODIES, MONOCLONAL; CORONARY THROMBOSIS; DRUG ADMINISTRATION SCHEDULE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; REGISTRIES; RISK FACTORS;

EID: 77956094332     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.02.002     Document Type: Article

References (29)

1. E.M. Antman, D.T. Anbe, and P.W. Armstrong ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction) Circulation 110 2004 e82 e292
2. G. De Luca, H. Suryapranata, and G.W. Stone Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials JAMA 293 2005 1759 1765
3. G. Montalescot, D. Antoniucci, and A. Kastrati Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients' data with long-term follow-up Eur Heart J 28 2007 443 449
4. T. Rakowski, J. Zalewski, and J. Legutko Early abciximab administration before primary percutaneous coronary intervention improves infarct-related artery patency and left ventricular function in high-risk patients with anterior wall myocardial infarction: a randomized study Am Heart J 153 2007 360 365
5. J. Godicke, M. Flather, and M. Noc Early versus periprocedural administration of abciximab for primary angioplasty: a pooled analysis of 6 studies Am Heart J 150 2005 1015
6. F. Bellandi, M. Maioli, M. Leoncini, A. Toso, and R.P. Dabizzi Early abciximab administration in acute myocardial infarction treated with primary coronary intervention Int J Cardiol 108 2006 36 42
7. M. Maioli, F. Bellandi, M. Leoncini, A. Toso, and R.P. Dabizzi Randomized early versus late abciximab in acute myocardial infarction treated with primary coronary intervention (RELAx-AMI Trial) J Am Coll Cardiol 49 2007 1517 1524
8. G. De Luca, M. Gibson, and F. Bellandi Early Glycoprotein IIb-IIIa inhibitors in Primary angioplasty (EGYPT) cooperation. An individual patient's data meta-analysis Heart 94 2008 548 558
9. G. Guagliumi, G.W. Stone, and D.A. Cox Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: results from the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial Circulation 110 2004 1598 1604 (Pubitemid 39297982)
10. K.P. Alexander, L.K. Newby, and P.W. Armstrong Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on clinical cardiology: in collaboration with the Society of Geriatric Cardiology Circulation 115 2007 2570 2589
11. D. Dudek, Z. Siudak, and M. Janzon European Registry on patients with st-elevation myocardial infarction transferred for mechanical reperfusion with a special focus on early administration of abciximab - EUROTRANSFER Registry Am Heart J 156 2008 1147 1154
12. A. Prasad, G.W. Stone, and E. Aymong Impact of ST-segment resolution after primary angioplasty on outcomes after myocardial infarction in elderly patients: an analysis from the CADILLAC trial Am Heart J 147 2004 669 675
13. G. De Luca, A.W. van 't Hof, and J.P. Ottervanger Ageing, impaired myocardial perfusion, and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty Eur Heart J 26 2005 662 666 (Pubitemid 40516877)
14. V.S. DeGeare, G.W. Stone, and L. Grines Angiographic and clinical characteristics associated with increased in-hospital mortality in elderly patients with acute myocardial infarction undergoing percutaneous intervention (a pooled analysis of the primary angioplasty in myocardial infarction trials) Am J Cardiol 86 2000 30 34
15. W.B. Batchelor, K.J. Anstrom, and L.H. Muhlbaier Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: results in 7472 octogenarians. National Cardiovascular Network Collaboration J Am Coll Cardiol 36 2000 723 730
16. A.T. Yan, R.T. Yan, and M. Tan Treatment and one-year outcome of patients with renal dysfunction across the broad spectrum of acute coronary syndromes Can J Cardiol 22 2006 115 120
17. J.P. Henriques, F. Zijlstra, and J.P. Ottervanger Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction Eur Heart J 23 2002 1112 1117
18. G. Montalescot, P. Barragan, and O. Wittenberg Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction N Engl J Med 344 2001 1895 1903 (Pubitemid 32553358)
19. D. Antoniucci, A. Rodriguez, and A. Hempel A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction J Am Coll Cardiol 42 2003 1879 1885
20. H.M. Sadeghi, C.L. Grines, and H.R. Chandra Percutaneous coronary interventions in octogenarians. glycoprotein IIb/IIIa receptor inhibitors' safety profile J Am Coll Cardiol 42 2003 428 432
21. G. Molinari, I. Nicoletti, and M. De Benedictis Safety and efficacy of the percutaneous radial artery approach for coronary angiography and angioplasty in the elderly J Invasive Cardiol 17 2005 651 654
22. G.W. Stone, B. Witzenbichler, and G. Guagliumi Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2008 2218 2230
23. D. Dudek, K. Zmudka, and B. Witzenbichler Impact of advanced age on the safety and effectiveness of bivalirudin in patients with acute myocardial infarction undergoing primary angioplasty: The HORIZONS AMI trial J Am Coll Cardiol 51 2008 B67
24. S. Zorman, D. Zorman, and M. Noc Effects of abciximab pretreatment in patients with acute myocardial infarction undergoing primary angioplasty Am J Cardiol 90 2002 533 536 (Pubitemid 35246047)
25. M. Gyongyosi, H. Domanovits, and W. Benzer Use of abciximab prior to primary angioplasty in STEMI results in early recanalization of the infarct-related artery and improved myocardial tissue reperfusion - results of the Austrian multi-centre randomized ReoPro-BRIDGING study Eur Heart J 25 2004 2125 2133
26. H.M. Gabriel, J.A. Oliveira, P.C. da Silva, J.M. da Costa, and J.A. da Cunha Early administration of abciximab bolus in the emergency department improves angiographic outcome after primary PCI as assessed by TIMI frame count: results of the early ReoPro administration in myocardial infarction (ERAMI) trial Catheter Cardiovasc Interv 68 2006 218 224
27. S.G. Ellis, M. Tendera, and M.A. de Belder Facilitated PCI in patients with ST-elevation myocardial infarction N Engl J Med 358 2008 2205 2217
28. E.M. Antman, M. Hand, and P.W. Armstrong 2007 Focused update of the ACC/AHA 2004 guidelines for the management of patients with st-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association task force on practice guidelines: developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 writing group to review new evidence and update the ACC/AHA 2004 guidelines for the management of patients with st-elevation myocardial infarction, writing on behalf of the 2004 Writing Committee Circulation 117 2008 296 329
29. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150